Neuralstem (CUR -13.7%) continues to give back it's big gains from yesterday, declining again today after pricing a secondary offering for 7M shares at $1.00 per share, a 27% discount to its previous close. The company intends to use the funds for clinical trials, R&D as well as other general purposes.
Neuralstem (CUR -13.7%) continues to give back it's big gains from yesterday, declining again...
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs